News & Insights
Sort By
Insights 1 result
Insights
|April 22, 2020
California Consumer Privacy Act: California-Based Employees and Job Applicants
This alert is the first in our series of Privacy Topics: Practical Guidance from Gunderson Dettmer – a collection of practical privacy and data security guidance and accompanying materials designed to facilitate your company’s compliance efforts. Today’s alert focuses on the rights of CA-based employees (including job applicants) under the California Consumer Privacy Act (CCPA) as it stands on April 22, 2020.
Client News 15 Results
Client News
|January 10, 2025
City Therapeutics Enters Strategic Collaboration with Bausch + Lomb
City Therapeutics, a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, announces its strategic collaboration with global eye health leader, Bausch + Lomb
Client News
|October 8, 2024
City Therapeutics Announces Launch with $135M Series A Financing
City Therapeutics announces its launch and $135 million Series A financing led by ARCH Ventures
Client News
|July 26, 2022
Replicate Bioscience announces its licensing agreement to collaborate with Precision NanoSystems to help support the development of up to 15 new genomic medicine products.
Firm News 1 result
Firm News
|April 25, 2022
Gunderson Dettmer Recognized in 2022 Mergers and Acquisitions Top Middle-Market Deals of the Year
Gunderson Dettmer was recognized as a winner in the 15th Annual Mergers and Acquisitions Top Middle-Market Deals of the Year for its representation of Foresight Sports in its acquisition by Vista Outdoor and The Athletic in its acquisition by The New York Times, two out of the thirteen winning deals for the categories Media and Consumer Products and Outdoor Recreation.